Since both CCR9 and ITGA4 are direct targets of RA (46, 47), we hypothesized that CD161+ T cells express higher levels of CCR9 and integrin α4β7 because they have been exposed to a RA signal during T cell differentiation, whereas CD161− T cells have not been previously exposed. Here, CCR9 is linked to rheumatoid arthritis.